COLUMBIA, MD
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)MEDSTAR HEALTH RESEARCH INSTITUTE INC, founded in 1963, is a mid-sized nonprofit that reported $74.1M in total revenue in fiscal year 2024. Revenue surged 25% from the prior year, signaling strong growth momentum.
MEDSTAR HEALTH RESEARCH INSTITUTE (THE RESEARCH INSTITUTE) IS THE RESEARCH ARM FOR MEDSTAR HEALTH, PROVIDING SCIENTIFIC, ADMINISTRATIVE, AND REGULATORY SUPPORT FOR RESEARCH PROGRAMS THAT COMPLEMENT THE KEY CLINICAL SERVICES AND TEACHING PROGRAMS IN ALL HOSPITALS IN THE SYSTEM. THE RESEARCH INSTITUTE SUPPORTS CLINICAL RESEARCH PERFORMED BY ATTENDING MEDICAL STAFF, AND FULL-TIME RESEARCH INVESTIGATORS. THE RESEARCH INSTITUTE AND ITS INVESTIGATORS PROVIDE PATIENTS ACCESS TO THE LATEST CLINICAL TRIALS, CUTTING-EDGE DIAGNOSTICS, AND INNOVATIVE THERAPIES WHILE DISCOVERING NEW WAYS TO TREAT PEOPLE THROUGH HEALTH SERVICES AND CLINICAL RESEARCH. WITH MORE THAN 1,000 ACTIVE RESEARCH STUDIES AND CLINICAL TRIALS CONDUCTED ACROSS 40 DIFFERENT CARE SITES AND OVER 900 PEER-REVIEWED PUBLICATIONS IN FISCAL YEAR 2025, THE RESEARCH INSTITUTE'S PORTFOLIO INCLUDES CLINICAL AND INVESTIGATIVE WORK ACROSS CLINICAL SERVICE LINES INCLUDING CARDIOVASCULAR, ONCOLOGY, DIABETES, ORTHOPAEDICS, NEUROLOGY, GASTROENTEROLOGY, REHABILITATION, CRITICAL CARE, WOMEN'S HEALTH, HEALTHCARE QUALITY AND PATIENT SAFETY.
THE MEDSTAR HEALTH RESEARCH INSTITUTE'S HIGHLY QUALIFIED SCIENTISTS AND INVESTIGATORS CONDUCT CUTTING EDGE CLINICAL RESEARCH. THE RESEARCH COVERS MANY AREAS AND TYPES OF RESEARCH ACROSS THE FOLLOWING...
THE MEDSTAR HEALTH RESEARCH INSTITUTE'S HIGHLY QUALIFIED SCIENTISTS AND INVESTIGATORS CONDUCT CUTTING EDGE CLINICAL RESEARCH. THE RESEARCH COVERS MANY AREAS AND TYPES OF RESEARCH ACROSS THE FOLLOWING COMPREHENSIVE RESEARCH NETWORKS: CARDIOVASCULAR, HEALTHCARE DELIVERY, CANCER, MEDICAL AND SURGICAL SERVICES, ORTHOPEDICS AND SPORTS MEDICINE, NEUROSCIENCES, REHABILITATION AND CORE SERVICES. FROM BENCH TO BEDSIDE AND INTO THE COMMUNITY, ASSOCIATES ACROSS THE RESEARCH INSTITUTE WORK TO ADVANCE THE SCIENTIFIC UNDERSTANDING OF DISEASE AND POINT THE WAY TO BETTER AND MORE EFFECTIVE TREATMENTS. AS THE RESEARCH FOCUSED ENTITY OF MEDSTAR HEALTH, THIS IS OUR CONTRIBUTION TO THE HEALING WORK PERFORMED THROUGHOUT THE SYSTEM AND IN THE COMMUNITIES WE SERVE. THE RESEARCH INSTITUTE IS HOME TO MORE THAN 400 INVESTIGATORS AND SCIENTISTS WHO ARE NATIONALLY AND INTERNATIONALLY RECOGNIZED FOR THEIR EXPERTISE IN EPIDEMIOLOGY, HEALTHCARE DELIVERY, HEALTH ECONOMICS, HUMAN FACTORS, MEDICAL ENGINEERING, IMPLEMENTATION SCIENCE, DRUG DEVELOPMENT, PHYSIOLOGY, SOCIAL WORK, AND REHABILITATION. THEY WORK ALONGSIDE CARE TEAMS TO DISCOVER BETTER CLINICAL INTERVENTIONS, SERVE ON EDITORIAL REVIEW BOARDS OF PROMINENT SCIENTIFIC MEDICAL JOURNALS, PRESENT AT NATIONAL MEDICAL AND SCIENTIFIC MEETINGS, AND ADVANCE THE STANDARD OF CARE FOR MEDSTAR HEALTH PATIENTS AND WITHIN THE FIELD OF MEDICINE. THE MEDSTAR HEALTH RESEARCH INSTITUTE IS ALSO HOME TO D.C. SAFE BABIES SAFE MOMS, AN INITIATIVE THAT SEEKS TO USE RESEARCH, EVIDENCE-BASED HEALTHCARE, AND PARTNERSHIPS WITH COMMUNITY-BASED ORGANIZATIONS TO CREATE POSITIVE, SUSTAINABLE CHANGE IN MATERNAL AND INFANT HEALTH.
FEDERICO ASCH, M.D. AND SUZANNE SIMKOVICH PARTICIPATED IN A SUPPLEMENTAL NONQUALIFIED RETIREMENT PLAN DESCRIBED IN SECTION 457(F) DURING THIS YEAR.
CARDIOVASCULAR RESEARCH IS RESPONSIBLE FOR COORDINATING AND PERFORMING A WIDE VARIETY OF CARDIOLOGY RESEARCH DEDICATED TO DEVELOPING NEW DIAGNOSTIC AND THERAPEUTIC TECHNOLOGIES TO ENHANCE PATIENT...
CARDIOVASCULAR RESEARCH IS RESPONSIBLE FOR COORDINATING AND PERFORMING A WIDE VARIETY OF CARDIOLOGY RESEARCH DEDICATED TO DEVELOPING NEW DIAGNOSTIC AND THERAPEUTIC TECHNOLOGIES TO ENHANCE PATIENT CARE AND SAVE LIVES. AREAS OF SPECIALIZATION INCLUDE INTERVENTIONAL CARDIOLOGY DEVICES, CARDIOVASCULAR IMAGING AND APPLICATIONS OF ARTIFICIAL INTELLIGENCE, HEART FAILURE, ARRYTHMIAS AND OUTCOMES RESEARCH.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2024 | 2023 | Change | |
|---|---|---|---|
| Revenue | $74,089,762 | $59,461,537 | +0.2% |
| Expenses | $78,357,235 | $69,535,678 | +0.1% |
| Net Income | $-4,267,473 | $-10,074,141 | -0.6% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| SOO Y BANG MSHA | DIRECTOR (UNTIL 10/2024) | 1.00 |
Director
|
$0 | $0 | $0 |
| EDWARD B HEALTON MD | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| NORMAN J BEAUCHAMP JR MD | DIRECTOR (AS OF 9/2024) | 1.00 |
Director
|
$0 | $0 | $0 |
| DALE MCELVEEN | DIRECTOR (AS OF 9/2024) | 1.00 |
Director
|
$0 | $0 | $0 |
| DEREK GRIFFITH PHD | DIRECTOR (UNTIL 1/2025) | 1.00 |
Director
|
$0 | $0 | $0 |
| SPIROS DIMOLITSAS PHD | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| STEPHEN RT EVANS MD | DIRECTOR | 1.00 |
Director
|
$0 | $66,390 | $3,091,812 |
| SARAH GREENE MPH | CHAIR | 1.00 |
Director
|
$0 | $0 | $0 |
| PRENTICE PARRISH | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| ANAND SHAH MD | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| STEVEN SMITH MD | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| FRED BUTLER JR | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| JEFFREY B LEE | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| JONATHAN M YOUNG PHD | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| PAMELA TENAERTS MD | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| TAMIKA AUGUSTE MD | DIRECTOR | 1.00 |
Director
|
$0 | $34,051 | $757,499 |
| NEIL J WEISSMAN MD | PRESIDENT/DIRECTOR | 40.00 |
Officer
Director
|
$1,185,542 | $62,330 | $1,247,872 |
| WILLIAM GAYNE | TREASURER (UNTIL 8/2024) | 20.00 |
Officer
|
$188,029 | $31,059 | $407,117 |
| KEITH SHINER | SECRETARY | 1.00 |
Officer
|
$0 | $34,699 | $356,263 |
| AMANDA BARASH | TREASURER (AS OF 11/2024) | 20.00 |
Officer
|
$14,151 | $22 | $28,324 |
| STEPHAN QUIRICONI | INTERIM TREASURER (08/2024-11/2024) | 20.00 |
Officer
|
$56,586 | $0 | $113,172 |
| FEDERICO ASCH MD | SCIENTIFIC DIRECTOR | 40.00 |
Highest
|
$600,912 | $27,669 | $628,581 |
| RAJ RATWANI PHD | VP SCIENTIFIC AFFAIRS | 40.00 |
Highest
|
$441,548 | $19,999 | $461,547 |
| SETH KREVAT MD | MEDICAL DOCTOR | 40.00 |
Highest
|
$374,309 | $21,094 | $395,403 |
| WILLIAM WEINTRAUB | PHYSICIAN INVESTIGATOR | 40.00 |
Highest
|
$381,146 | $28,408 | $409,554 |
| SUZANNE SIMKOVICH | PHYSICIAN INVESTIGATOR | 40.00 |
Highest
|
$455,976 | $30,550 | $486,526 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2025 | $74,089,762 | $78,357,235 | $46,768,247 | $-4,267,473 |
| 2024 | No data | No data | No data | No data |
| 2023 | $52,774,409 | $63,252,010 | $40,740,989 | $-10,477,601 |
| 2022 | $50,039,397 | $58,646,314 | $46,788,307 | $-8,606,917 |
| 2021 | $47,234,985 | $52,955,266 | $50,666,334 | $-5,720,281 |
| 2020 | $39,716,879 | $44,791,996 | $57,300,150 | $-5,075,117 |
| 2019 | $36,064,856 | $44,800,868 | $23,488,796 | $-8,736,012 |
| 2018 | $33,191,605 | $40,877,231 | $21,596,713 | $-7,685,626 |
Compare MEDSTAR HEALTH RESEARCH INSTITUTE INC with other nonprofits in Maryland and across the country.